Dr Forbes said that by 1983, doctors were already starting to observe patients to see if there were early signs of AIDS. Read more about Dr Forbes said that by 1983, doctors were already starting to observe patients to see if there were early signs of AIDS.
By 1979, the issue of chronic hepatitis dominated everyone's lives. Read more about By 1979, the issue of chronic hepatitis dominated everyone's lives.
During 1978, before the complications had become apparent, Dr Forbes described the recent move to home treatment as highly valuable for patients. Read more about During 1978, before the complications had become apparent, Dr Forbes described the recent move to home treatment as highly valuable for patients.
Dr Forbes agrees with a letter written by Dr John Cash on 24 January 1976, with held that that the importation of Factor VIII concentrates was "bringing with it a potentially lethal virus into the whole community" in reference to hepatitis. Read more about Dr Forbes agrees with a letter written by Dr John Cash on 24 January 1976, with held that that the importation of Factor VIII concentrates was "bringing with it a potentially lethal virus into the whole community" in reference to hepatitis.
Evidence presented to the Penrose Inquiry by Dr Forbes held that the risk of dying due to a bleed outweighed the possible downside of using factor concentrates. Read more about Evidence presented to the Penrose Inquiry by Dr Forbes held that the risk of dying due to a bleed outweighed the possible downside of using factor concentrates.
Evidence presented to the Penrose Inquiry by Dr Forbes stated that the majority of discussions taking place around 1975 were centred around the types of donors used to give plasma in commercial centres. Read more about Evidence presented to the Penrose Inquiry by Dr Forbes stated that the majority of discussions taking place around 1975 were centred around the types of donors used to give plasma in commercial centres.
The annual return taken from Glasgow in 1979 saw a reduction in the use of cryoprecipitate and an increase in the use of concentrates, both NHS and (in particular) commercial Read more about The annual return taken from Glasgow in 1979 saw a reduction in the use of cryoprecipitate and an increase in the use of concentrates, both NHS and (in particular) commercial
The annual return taken from Glasgow in 1978, held that the use of concentrates (more NHS than commercial, although Profilate, Factorate, Koate and Hemofil were all used) exceeded the use of cryoprecipitate. Read more about The annual return taken from Glasgow in 1978, held that the use of concentrates (more NHS than commercial, although Profilate, Factorate, Koate and Hemofil were all used) exceeded the use of cryoprecipitate.
The annual return taken from Glasgow in 1977, held that the use of concentrates (more NHS than commercial, although Profilate, Factorate, Koate and Hemofil were all used) exceeded the use of cryoprecipitate. Read more about The annual return taken from Glasgow in 1977, held that the use of concentrates (more NHS than commercial, although Profilate, Factorate, Koate and Hemofil were all used) exceeded the use of cryoprecipitate.
The annual return taken from Glasgow in 1976, held that the use of concentrates (more NHS than commercial, although Profilate, Factorate, Koate and Hemofil were all used) exceeded the use of cryoprecipitate. Read more about The annual return taken from Glasgow in 1976, held that the use of concentrates (more NHS than commercial, although Profilate, Factorate, Koate and Hemofil were all used) exceeded the use of cryoprecipitate.